The science
The evidence on stretch-mark prevention is clear and negative, and it frames everything else. Striae gravidarum are dermal tears — disrupted collagen and elastin under mechanical stretch, driven by genetics, rate of weight gain and hormonal changes — and the 2012 Cochrane review of topical preparations for preventing them, covering six randomised or quasi-randomised trials in 800 women, found no statistically significant difference in stretch-mark development between active preparations and placebo or no treatment (average risk ratio 0.74, 95 percent CI 0.53 to 1.03), and no difference in severity; the trials included olive oil, cocoa butter and Centella-based creams. A topical cannot reach the dermal collagen that fails, and this product's formulation does not change that. What the formulation can do is barrier work, and here Atopalm's technology is genuinely distinctive. Multi-Lamellar Emulsion uses a synthetic pseudoceramide — myristoyl/palmitoyl oxostearamide/arachamide MEA — with fatty acids, phytosterols and emulsifiers to form a lamellar liquid-crystal phase that mimics stratum corneum lipids; a 2024 randomised controlled trial in Dermatol Ther (Heidelb) of an MLE moisturiser containing a pseudoceramide and a sphingosine kinase activator reported improvement in atopic dermatitis severity and barrier measures, and earlier NeoPharm work in Ann Dermatol showed a physiological lipid mixture preventing barrier dysfunction after UVB and X-ray injury. That is evidence for reduced transepidermal water loss and improved comfort on stretched, dry skin, and it is the honest basis of this cream's value. The supporting ingredients divide cleanly. Beta-glucan and Tremella fuciformis polysaccharide are effective film-forming humectants; panthenol, allantoin and bisabolol have long records as anti-irritants; olive, rapeseed and jojoba oils are occlusive emollients. Acetyl hexapeptide-8, by contrast, is a facial peptide whose proposed action on SNARE-complex signalling in expression lines has no bearing on body dermis under stretch, and Tremella is a sugar, not collagen. The essential oils raise the one safety question: bergamot oil's bergapten (5-methoxypsoralen) is a potent UVA photosensitiser, with the action spectrum characterised in J Dermatol in 1994 and bullous phototoxic reactions to aromatherapy-grade oil reported in J Am Acad Dermatol in 2001; furocoumarin-free bergamot exists, but the label does not specify it, and litsea cubeba's citral is a frequent contact allergen. No trial of this finished product has been published.
References 4 ShowHide
- Topical preparations for preventing stretch marks in pregnancy — Cochrane Database of Systematic Reviews (2012)
- Efficacy of a Multi-lamellar Emulsion Containing a Synthetic Sphingosine Kinase 1 Activator and Pseudoceramide in Patients with Atopic Dermatitis: A Randomized Controlled Trial — Dermatology and Therapy (2024)
- Accidental bullous phototoxic reactions to bergamot aromatherapy oil — Journal of the American Academy of Dermatology (2001)
- Action spectrum for bergamot-oil phototoxicity measured by sunburn cell counting — Journal of Dermatology (1994)